Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × ferric gluconate × Classical hematology × Clear all

Phase

Status

Completed 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

Peripheral Blood Stem Cell Transplantation 4 fludarabine phosphate 2 Whole-Body Irradiation 2 Methotrexate 2 Cyclosporine 2 Cyclophosphamide 2 Busulfan 2 siltuximab 1 magrolimab 1 hetrombopag 1 fludarabine 1 ferric gluconate 1 decitabine and cedazuridine drug combination 1 ceftolozane, tazobactam drug combination 1 Transplantation 1 Tacrolimus 1 Radiotherapy 1 Pentostatin 1 Mycophenolic Acid 1 Micafungin 1 Meropenem 1 Iron-Dextran Complex 1 Iron 1 In Situ Hybridization, Fluorescence 1 Immunoenzyme Techniques 1 Holistic Health 1 Genotype 1 Flow Cytometry 1 Filgrastim 1 Erythrocyte Transfusion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00481624 2018-03-05

Procrit

University of Louisville

Phase 2 Withdrawn

Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡